Rosen Law Firm Urges Inovio Pharmaceuticals, Inc. (NASDAQ: INO) Stockholders to Contact the Firm for Information About Their Rights

Core Viewpoint - A class action lawsuit has been announced by Rosen Law Firm on behalf of purchasers of securities of Inovio Pharmaceuticals, Inc. for the period between October 10, 2023, and December 26, 2025, indicating potential legal challenges for the company [1]. Company Overview - Inovio Pharmaceuticals, Inc. is described as a biotechnology company focused on the discovery, development, and commercialization of DNA medicines aimed at treating and protecting individuals from diseases, including those associated with human papillomavirus (HPV) [1].